DaVita
DVA
$98.40
Share price
-0.34%
Change (1 day)
2.70%
Change (1 year)
Categories
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.
P/S ratio for DaVita (DVA)
P/S ratio as of June 2023 (TTM): 0.7677
According to DaVita's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.76774. At the end of 2023 the company had a P/S ratio of 0.6286.
P/S ratio history for DaVita from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.6286 | 8.47% |
| 2022 | 0.5795 | -41.92% |
| 2021 | 0.9977 | -12.36% |
| 2020 | 1.14 | 37.3% |
| 2019 | 0.8291 | 10.43% |
| 2018 | 0.7508 | -19.06% |
| 2017 | 0.9275 | 7.92% |
| 2016 | 0.8595 | -18.99% |
| 2015 | 1.06 | -16.88% |
| 2014 | 1.28 | 11.17% |
| 2013 | 1.15 | -18.89% |
| 2012 | 1.42 | 39.55% |
| 2011 | 1.01 | -1.96% |
| 2010 | 1.03 | 4.41% |
| 2009 | 0.9910 | 9.02% |
| 2008 | 0.9090 | -20.73% |
| 2007 | 1.15 | -5.96% |
| 2006 | 1.22 | -29.75% |
| 2005 | 1.74 | 2.4% |
| 2004 | 1.70 | 37.89% |
| 2003 | 1.23 | 51.61% |
| 2002 | 0.8108 | -35.37% |
| 2001 | 1.25 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Universal Health Services
UHS | 0.7004 | -8.78% | 🇺🇸 USA |
 LabCorp LH | 1.30 | 69.71% | 🇺🇸 USA |
 Tenet Healthcare THC | 0.3909 | -49.09% | 🇺🇸 USA |
 Pediatrix Medical Group MD | 0.5916 | -22.95% | 🇺🇸 USA |